Open Access Green as soon as Postprint is submitted to ZB.
STZ causes depletion of immune cells in sciatic nerve and dorsal root ganglion in experimental diabetes.
J. Neuroimmunol. 306, 76-82 (2017)
Streptozotocin (STZ) treatment, a common model for inducing diabetes in rodent models, induces thermal hyperalgesia and neuronal toxicity independently of hyperglycemia by oxidizing and activating TRPA1 and TRPV1. Following treatment with STZ, CD45+ immune cells were found to be depleted in sciatic nerve (SN) and DRG in mice, prior to hyperglycemia. Macrophages were also lost in DRG and NFκB-p65-activation was increased in SN macrophages. Immune cells were significantly reduced in both SN and DRG up to three weeks, post-treatment. Loss of PNS-resident macrophages in response to STZ-mediated toxicity may affect the regenerative capacity of the nerve in response to further injury caused by diabetes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
2.720
0.000
12
12
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Diabetic Neuropathy ; Experimental Diabetes ; Macrophage ; Neurotoxicity; Thermal Hyperalgesia; Scavenger-receptor; Sensitive Method; Spinal-cord; Streptozotocin; Macrophages; Neuropathy; Pain; Regeneration; Expression
Language
english
Publication Year
2017
HGF-reported in Year
2017
ISSN (print) / ISBN
0165-5728
e-ISSN
1872-8421
Journal
Journal of Neuroimmunology
Quellenangaben
Volume: 306,
Pages: 76-82
Publisher
Elsevier
Publishing Place
Amsterdam
Reviewing status
Peer reviewed
Institute(s)
Institute of Diabetes and Cancer (IDC)
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-501900-251
PubMed ID
28385191
WOS ID
WOS:000400037400012
Scopus ID
85015725291
Erfassungsdatum
2017-06-21